The United States Federal Drug Administration (FDA) recently approved a label extension for Revolution Plus (selamectin and sarolaner topical solution).
SignalPET, which was founded in 2018, uses AI and machine learning technology to analyze radiographs and standardize interpretation, which helps to reduce interpretation errors, increase film...
